相关实验视频

Updated: Jun 13, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

针对头部和部状细胞癌的TGF-β向疗法的进展

William R Britton^1,2, Isabel Cioffi¹, Corinne Stonebraker¹

¹Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.

|September 14, 2024

概括

转换头部和部状细胞癌 (HNSCC) 治疗需要理解TGF-β信号传递. 本文审查了TGF-β抑制剂的研究.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学
翻译医学是一种翻译医学.

背景情况:

头部和部状细胞癌 (HNSCC) 是一个重要的全球健康挑战,对于晚期疾病的治疗选择有限.
单细胞转录组学揭示了TGF-β信号传递在HNSCC侵入性,治疗耐药性和免疫逃避中的作用.
在TGF-β信号传递中介癌症相关纤维细胞和间酶体癌细胞之间的相互作用.

研究的目的:

对HNSCC中TGF-β抑制剂的临床前和临床发现进行批判性审查.
在HNSCC.中探索TGF-β抑制剂治疗患者分层的潜力.
重新评估TGF-β通路作为HNSCC的治疗点.

主要方法:

对HNSCC中TGF-β抑制剂的临床前研究的审查.
对HNSCC中TGF-β抑制剂的已完成和正在进行的临床试验数据的分析.
探索涉及TGF-β信号传递的单细胞转录组数据.

主要成果:

临床前数据显示TGF-β抑制剂具有显著的抗瘤潜力.
临床试验的结果令人丧,这表明临床应用存在挑战.
TGF-β通路与HNSCC的侵入性,耐药性和免疫逃避有关.

结论:

尽管临床前有希望,但TGF-β抑制剂在HNSCC中的临床益处仍然难以捉摸.
患者分层可能对实现TGF-β抑制剂的治疗潜力至关重要.
需要进一步的研究来优化TGF-β抑制剂策略用于HNSCC治疗.

关键词:

在 BCA-101 中,LY3200882 这是一个很好的机会.这就是SHR-1701的原因.在TGF-β的基础上.班特拉夫斯普阿尔法阿尔法路径交叉接收方式表皮细胞到介质细胞的过渡.头部和部状细胞癌瘤

更多相关视频

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.